HVTN 302

A phase 1, randomized, open-label clinical trial to evaluate the safety and immunogenicity of HIV trimer mRNA vaccines in healthy, HIV-uninfected adult participants.

Need additional information?

Full Name: (required)

Age:

Race:

Black or African American

Latino

White

API

American Indian or Alaska Native

Other

Gender:

Male

Female

Transgender

Gender Non-binary

Phone: (required)

Email: (required)

Best time to contact:

Special contact information:

How did you hear about us?

Facebook

Instagram/Twitter

Flyer

Dating App (Grindr, Growlr, Adam4Adam, etc.)

Online

Word-of-mouth

Please indicate if you heard about us by any of these means:

Print Ad:

Community Meeting:

Special Event:

Other:

VSP